| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |